February 3, 2017, WINOOSKI VT, USA — BioTek has been granted US patent 9,557,217 for imaging and microplate reading in one instrument. The intellectual property protected by this patent is used in BioTek’s award winning line of Cytation™ Cell Imaging Multi-Mode readers. Other patents are pending.
Cytation offers fluorescence, brightfield, color brightfield and phase contrast imaging up to 60x, and multi-mode detection optics that include fluorescence intensity, luminescence, absorbance, and advanced measurements such as fluorescence polarization, time-resolved fluorescence and AlphaScreen®. Cytation systems are ideally suited to live cell assays, with incubation to 65 °C, shaking, plus available CO2/O2 control. Gen5™ Microplate Reader and Imager Software controls all imaging and multi-mode instrument operations, and provides quantitative and qualitative image and data analysis for a wide range of applications including cell migration, label-free cell counting, phenotypic analysis, DNA/RNA quantification or ROS assays.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers, and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. BioTek espouses a "Think Possible" approach that sets the tone for fresh ideas, unsurpassed customer service, and original innovations.
AlphaScreen is a registered trademark of PerkinElmer, Inc.